Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Neurometrix Inc (NURO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,888
  • Shares Outstanding, K 2,350
  • Annual Sales, $ 12,030 K
  • Annual Income, $ -14,910 K
  • 36-Month Beta 0.32
  • Price/Sales 0.15
  • Price/Cash Flow N/A
  • Price/Book 1.08

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.65 +16.97%
on 12/26/17
2.96 -34.80%
on 01/17/18
+0.23 (+13.53%)
since 12/19/17
3-Month
1.45 +33.10%
on 12/07/17
2.96 -34.80%
on 01/17/18
+0.21 (+12.21%)
since 10/19/17
52-Week
1.45 +33.10%
on 12/07/17
6.72 -71.28%
on 01/26/17
-3.59 (-65.04%)
since 01/19/17

Most Recent Stories

More News
NeuroMetrix and GlaxoSmithKline Consumer Healthcare Announce Strategic Collaboration to Develop and Expand Access to Quell Wearable Pain Relief Technology

NeuroMetrix, Inc. (Nasdaq:NURO) announced today a collaboration with GlaxoSmithKline (NYSE:GSK), one of the world's largest science-led global healthcare companies, involving Quell Wearable Pain Relief...

NURO : 1.93 (-7.21%)
GSK : 38.20 (+0.08%)
NeuroMetrix Reports Preliminary 2017 Financial Highlights

NeuroMetrix, Inc. (Nasdaq:NURO) today reported preliminary financial highlights for the fourth quarter and for the full year 2017.

NURO : 1.93 (-7.21%)
NeuroMetrix CEO to Participate in CES 2018 Panel on Opioid Crisis

NeuroMetrix, Inc. (Nasdaq:NURO) announced today that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, will participate in a panel at the Digital Health Summit at CES 2018. The panel,...

NURO : 1.93 (-7.21%)
NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 9,827,420. The patent covers novel technology that enhances Quell(R)...

NURO : 1.93 (-7.21%)
NeuroMetrix Closes $3.5 Million Equity Offering

NeuroMetrix, Inc. (NASDAQ: NURO) today closed a $3.5 million private placement of 3,500 shares of Series F convertible preferred stock at a price of $1,000 per share that are convertible...

NURO : 1.93 (-7.21%)
NeuroMetrix Reports Q3 2017 Financial Results

--Quell shipments of 15.6K devices are up 29% year-over-year

NURO : 1.93 (-7.21%)
Investor Network: NeuroMetrix, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / October 19, 2017 / NeuroMetrix, Inc. (NASDAQ: NURO) will be discussing their earnings results in their Q3 Earnings Call to be held October 19, 2017 at 8:00 AM Eastern Time.

NURO : 1.93 (-7.21%)
4 Medical Product Stocks Likely to Top Q3 Earnings Estimates

The MedTech space received a sudden jolt when White House pulled the plug on Obamacare subsidies.

NURO : 1.93 (-7.21%)
MGNX : 19.19 (+1.59%)
GWPH : 132.42 (+0.33%)
PRGO : 91.88 (+0.21%)
NeuroMetrix, Inc. Announces Date for 2017 Third Quarter Financial Results Conference Call

NeuroMetrix, Inc. (NASDAQ:NURO) announced today that it plans to issue its 2017 third quarter financial results before the opening of the market on Thursday October 19, 2017. The Company...

NURO : 1.93 (-7.21%)
NeuroMetrix Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City September 10-12th, 2017

NeuroMetrix, Inc. (Nasdaq:NURO) today announced it will be a presenting company at the 19th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC....

NURO : 1.93 (-7.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

See More

Business Summary

Neurometrix is a medical device company establishing a new standard of care through the design, development and sale of proprietary products used to diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes,...

See More

Key Turning Points

2nd Resistance Point 2.13
1st Resistance Point 2.03
Last Price 1.93
1st Support Level 1.87
2nd Support Level 1.81

See More

52-Week High 6.72
Fibonacci 61.8% 4.71
Fibonacci 50% 4.09
Fibonacci 38.2% 3.46
Last Price 1.93
52-Week Low 1.45

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.